Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYBR CyberCare the new look of healthcare -- Ignore unavailable to you. Want to Upgrade?

To: StockDung who wrote (747)	4/1/2000 3:11:00 PM
From: glenairlie	Respond to of 3392

Truthseeker. You finally highlighted the truth. The 1996 resignation was caused through prior management. That would mean current management was not in place at the time. And Ernst and Young replaced Grant Thornton LLP. Ernst and Young. Very well respected. Very capable of accurately auditing the financial statements of a growing company. Business is good. Parting comments by Grant Thornton ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT Ernst and Young, LLP has been engaged, on June 1, 1999, as the Company's independent certified public accountants. Grant Thornton, LLP has declined to stand for reelection as the Company's, (a Florida corporation), independent certified public accountants effective May 20, 1999. The decision to change accountants was approved by the Company's Board of Directors. There were no disagreements between the Company and Grant Thornton, LLP on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures in connection with the audits of the fiscal years ended December 31, 1998 and 1997. ITEM 5. OTHER EVENTS Inapplicable ITEM 6. RESIGNATIONS OF REGISTRANT'S DIRECTORS Inapplicable ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS Letters provided by former accountants. ITEM 8. CHANGE IN FISCAL YEAR Inapplicable EXHIBIT NO. PAGE 1.1 Letter dated May 28, 1999 of Grant Thornton, LLP 4 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Medical Industries of America, Inc. By: /s/ ARTHUR P. KOBRIN Arthur P. Kobrin, Senior Vice President & Chief Financial Officer (Principal Accounting Officer & Duly authorized Officer of the Registrant) By: /s/ PAUL C. PERSHES Paul C. Pershes, President & Director (Duly Authorized Director & Officer of the Registrant) Dated: June 1, 1999 3 TYPE: EX-1.1 SEQUENCE: 2 EXHIBIT 1.1 [GRANT THORNTON LLP LETTERHEAD] May 28, 1999 Securities and Exchange Commission Washington, D.C. 20549 RE: Medical Industries of America, Inc. File No. 0-20356 Dear Sir or Madam: We have read Item 4 of the Form 8-K of Medical Industries of America, Inc., dated May 20, 1999, and agree with the statements contained therein. Very truly yours, /s/ Grant Thornton, LLP JSB/ph